IL150037A0 - Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1, 2, 4] triazol, methods for producing them and pharmaceutical compositions containing them - Google Patents

Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1, 2, 4] triazol, methods for producing them and pharmaceutical compositions containing them

Info

Publication number
IL150037A0
IL150037A0 IL15003700A IL15003700A IL150037A0 IL 150037 A0 IL150037 A0 IL 150037A0 IL 15003700 A IL15003700 A IL 15003700A IL 15003700 A IL15003700 A IL 15003700A IL 150037 A0 IL150037 A0 IL 150037A0
Authority
IL
Israel
Prior art keywords
amino
triazol
phenyl
producing
methods
Prior art date
Application number
IL15003700A
Other languages
English (en)
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of IL150037A0 publication Critical patent/IL150037A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15003700A 1999-12-17 2000-12-14 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1, 2, 4] triazol, methods for producing them and pharmaceutical compositions containing them IL150037A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9915935A FR2802530B1 (fr) 1999-12-17 1999-12-17 Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant
PCT/FR2000/003536 WO2001044207A2 (fr) 1999-12-17 2000-12-14 Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2 4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
IL150037A0 true IL150037A0 (en) 2002-12-01

Family

ID=9553380

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15003700A IL150037A0 (en) 1999-12-17 2000-12-14 Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1, 2, 4] triazol, methods for producing them and pharmaceutical compositions containing them
IL150037A IL150037A (en) 1999-12-17 2002-05-04 Branched derivatives converted to the amino of 3-amino-1-phenyl-H1] 4,2,1 [H1-triazole, methods for their preparation and the pharmaceutical compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL150037A IL150037A (en) 1999-12-17 2002-05-04 Branched derivatives converted to the amino of 3-amino-1-phenyl-H1] 4,2,1 [H1-triazole, methods for their preparation and the pharmaceutical compositions containing them

Country Status (33)

Country Link
US (1) US6806282B2 (enExample)
EP (1) EP1242389B1 (enExample)
JP (1) JP4146641B2 (enExample)
KR (1) KR100705525B1 (enExample)
CN (1) CN1293061C (enExample)
AR (1) AR031837A1 (enExample)
AT (1) ATE264847T1 (enExample)
AU (1) AU780711B2 (enExample)
BR (1) BR0017023A (enExample)
CA (1) CA2398772C (enExample)
CO (1) CO5251379A1 (enExample)
CZ (1) CZ302460B6 (enExample)
DE (1) DE60010126T2 (enExample)
DK (1) DK1242389T3 (enExample)
EA (1) EA004957B1 (enExample)
EE (1) EE04778B1 (enExample)
ES (1) ES2219436T3 (enExample)
FR (1) FR2802530B1 (enExample)
HU (1) HUP0204080A3 (enExample)
IL (2) IL150037A0 (enExample)
IS (1) IS2315B (enExample)
ME (1) MEP12108A (enExample)
MX (1) MXPA02006033A (enExample)
NO (1) NO20022828L (enExample)
PL (1) PL203819B1 (enExample)
PT (1) PT1242389E (enExample)
RS (1) RS50289B (enExample)
SK (1) SK285994B6 (enExample)
TR (2) TR200401775T4 (enExample)
TW (1) TWI289554B (enExample)
UA (1) UA73333C2 (enExample)
WO (1) WO2001044207A2 (enExample)
ZA (1) ZA200204422B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7226920B2 (en) * 2003-08-06 2007-06-05 Vertex Pharmaceuticals Inc. Aminotriazole compounds useful as inhibitors of protein kinases
JO3019B1 (ar) 2006-04-19 2016-09-05 Janssen Pharmaceutica Nv ثلاثي مستبدل 4،2،1-ثلاثي زولات
ES2424023T3 (es) 2007-10-18 2013-09-26 Janssen Pharmaceutica N.V. 1,2,4-triazoles trisustituidos
JO2784B1 (en) 2007-10-18 2014-03-15 شركة جانسين فارماسوتيكا ان. في 5,3,1 - Triazole substitute derivative
MY152486A (en) * 2008-03-19 2014-10-15 Janssen Pharmaceutica Nv Trisubstituted 1,2,4 - triazoles as nicotinic acetylcholine receptor modulators
US8779158B2 (en) 2008-05-09 2014-07-15 Janssen Pharmaceutica Nv Trisubstituted pyrazoles as acetylcholine receptor modulators
EP2629616A4 (en) * 2010-10-21 2014-03-26 Merck Sharp & Dohme SUBSTITUTED AMINO-TRIAZOLYL-PDE10-HEMMER
LT3096756T (lt) 2014-01-21 2024-08-26 Neurocrine Biosciences, Inc. Crf1 receptoriaus antagonistai, skirti įgimtos antinksčių hiperplazijos gydymui
CN104059027B (zh) * 2014-07-01 2015-10-28 河北大学 一类含1,2,4-三唑的(e)-甲氧基亚氨基苯乙酸甲酯类化合物及其制备方法和用途
FI3984523T3 (fi) 2018-12-07 2025-10-21 Neurocrine Biosciences Inc Crf1-reseptorin antagonisti, lääkeformulaatioita ja niiden kiinteitä muotoja synnynnäisen lisämunuaisten liikakasvun hoitoon
KR20220069008A (ko) * 2019-09-25 2022-05-26 온코아렌디 테라퓨틱스 에스.에이. 5-(4-((2s,5s)-5-(4-클로로벤질)-2-메틸모르폴리노)피페리딘-1-일)-1h-1,2,4-트리아졸-3-아민의 생성 방법
CA3152590A1 (en) 2019-09-27 2021-04-01 Evan Smith Crf receptor antagonists and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3869167D1 (de) * 1987-03-27 1992-04-23 Kumiai Chemical Industry Co Phenyltriazol-derivate und insectizid.
US5795905A (en) * 1995-06-06 1998-08-18 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
FR2763337B1 (fr) * 1997-05-13 1999-08-20 Sanofi Sa Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
EP1242389A2 (fr) 2002-09-25
AU2525901A (en) 2001-06-25
ATE264847T1 (de) 2004-05-15
EA200200523A1 (ru) 2002-12-26
WO2001044207B1 (fr) 2002-06-06
PL203819B1 (pl) 2009-11-30
AR031837A1 (es) 2003-10-08
SK285994B6 (sk) 2008-01-07
EE04778B1 (et) 2007-02-15
CZ20022099A3 (cs) 2002-09-11
IL150037A (en) 2007-02-11
FR2802530B1 (fr) 2002-02-22
PT1242389E (pt) 2004-08-31
DE60010126D1 (de) 2004-05-27
CZ302460B6 (cs) 2011-06-01
UA73333C2 (en) 2005-07-15
EP1242389B1 (fr) 2004-04-21
CA2398772A1 (fr) 2001-06-21
HUP0204080A2 (hu) 2003-04-28
TR200401775T4 (tr) 2004-09-21
IS2315B (is) 2007-11-15
PL355811A1 (en) 2004-05-17
CO5251379A1 (es) 2003-02-28
SK8502002A3 (en) 2003-02-04
KR20020061002A (ko) 2002-07-19
ES2219436T3 (es) 2004-12-01
NO20022828D0 (no) 2002-06-13
WO2001044207A3 (fr) 2001-12-20
RS50289B (sr) 2009-09-08
TWI289554B (en) 2007-11-11
CN1293061C (zh) 2007-01-03
IS6402A (is) 2002-05-28
BR0017023A (pt) 2002-12-03
MEP12108A (en) 2010-06-10
AU780711B2 (en) 2005-04-14
EA004957B1 (ru) 2004-10-28
TR200201600T2 (tr) 2002-10-21
DE60010126T2 (de) 2005-04-28
CN1434808A (zh) 2003-08-06
WO2001044207A2 (fr) 2001-06-21
US20030162771A1 (en) 2003-08-28
DK1242389T3 (da) 2004-08-09
ZA200204422B (en) 2003-11-26
YU43902A (sh) 2005-03-15
JP4146641B2 (ja) 2008-09-10
CA2398772C (fr) 2011-07-05
MXPA02006033A (es) 2003-01-28
US6806282B2 (en) 2004-10-19
FR2802530A1 (fr) 2001-06-22
JP2003516975A (ja) 2003-05-20
WO2001044207A8 (fr) 2001-07-12
EE200200331A (et) 2003-06-16
NO20022828L (no) 2002-08-19
KR100705525B1 (ko) 2007-04-10
HUP0204080A3 (en) 2005-01-28
HK1055947A1 (en) 2004-01-30

Similar Documents

Publication Publication Date Title
AU4666996A (en) Substituted heterocyclic compounds, method of preparing them and pharmaceutical compositions in which they are present
IL134871A (en) Polymeric derivatives of camptothecins, process for producing such derivatives and pharmaceutical compositions containing them
HUP0000323A3 (en) N-substituted 2-cyanopyrrolidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0203316A3 (en) Amino-triazolopyridine derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0100731A3 (en) New oxazolidine-, thiazolidine-, pyrrolidine-and piperidin derivatives process for their preparation and pharmaceutical compositions containing them
HU9800291D0 (en) Use of amido-pirimidine derivatives for producing pharmaceutical compositions for inhibiting decrease of glucose-metabolismus
HUP9900120A3 (en) Benzosulfone derivatives, process for producing them and pharmaceutical compositions containing them
HUP0001555A3 (en) Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
HUP0202731A3 (en) O-anisamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP9802653A3 (en) Substituted imidazolidine derivatives, process for producing them, and pharmaceutical compositions containing them
HUP0201516A3 (en) 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0201753A3 (en) Pyridopyranoazepine derivatives, process for their preparation and pharmaceutical compositions containing them
AU2001269198A1 (en) Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
HUP0000664A3 (en) Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use of them for producing pharmaceutical compositions
HUP0203184A3 (en) Isoxazolecarboxamide derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0003053A3 (en) Crystalline forms of 33-epichloro-33-desoxyascomycin, process for their preparation and pharmaceutical compositions containing them
HUP9802121A3 (en) Imidazoline derivatives, process for producing them and pharmaceutical compositions containing them
IL150037A0 (en) Novel branched substituted amino derivatives of 3-amino-1-phenyl-1h[1, 2, 4] triazol, methods for producing them and pharmaceutical compositions containing them
HUP9901190A3 (en) Sulfonamide derivatives of imidazole, process for producing them and pharmaceutical compositions containing them
EG22344A (en) Process for preparing of novel pharmaceutical composition
HUP0202988A3 (en) Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one derivatives and their use as lipase inhibitors, process for their preparation and pharmaceutical compositions containing them
HUP0004663A3 (en) Substituted isoquinoline derivatives, process for producing them and use of them for producing pharmaceutical compositions as anticonvulsants and pharmaceutical compositions containing them
HUP0101234A2 (hu) Béta-karbolin-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0102895A3 (en) Cyclopentanone dihydropyridine derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
HUP0001773A3 (en) Substituted tetrahydropyridin derivatives, method of preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed